Literature DB >> 8894480

Natural history of impaired glucose tolerance: follow-up at Joslin Clinic.

J H Warram1, R J Sigal, B C Martin, A S Krolewski, J S Soeldner.   

Abstract

The goal of this study was to examine follow-up data on the offspring of two parents with NIDDM who have IGT to identify predictors of progression to NIDDM. The study group consisted of 80 individuals with IGT (WHO criteria), 28 of whom had IGT at baseline, and 52 who developed it during follow-up. Both an oral glucose tolerance test (OGTT) and an intravenous glucose tolerance test (IVGTT) were performed at baseline. After a median follow-up interval of 8 years, 35% had progressed to NIDDM, 37% had reverted to normal glucose tolerance, and 29% still had IGT. Those who progressed were younger and more obese than non-progressors. Glucose and insulin values from the OGTT that established the diagnosis of IGT were analysed by multiple logistic regression to determine which time points best discriminated between progressors and non-progressors. High insulin, but not glucose, values at 0 and 120 min distinguished progressors from non-progressors. Values at other sample times that were significantly different (p < 0.05) in progressors were: higher glucose values at 30, 45, and 60 min and higher insulin values at 90 and 180 min. Multiple logistic regression analysis of Bergman's minimal model parameters obtained from the IVGTTs performed at baseline demonstrated that, once IGT is established, low acute phase insulin secretion as well as low insulin sensitivity are significant predictors of progression to NIDDM.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8894480

Source DB:  PubMed          Journal:  Diabet Med        ISSN: 0742-3071            Impact factor:   4.359


  13 in total

1.  Screening for type 2 diabetes mellitus to prevent vascular complications: updated recommendations from the Canadian Task Force on Preventive Health Care.

Authors:  Denice S Feig; Valerie A Palda; Lorraine Lipscombe
Journal:  CMAJ       Date:  2005-01-18       Impact factor: 8.262

2.  The natural history of insulin secretory dysfunction and insulin resistance in the pathogenesis of type 2 diabetes mellitus.

Authors:  C Weyer; C Bogardus; D M Mott; R E Pratley
Journal:  J Clin Invest       Date:  1999-09       Impact factor: 14.808

3.  Association of sleep apnea and type II diabetes: a population-based study.

Authors:  Kevin J Reichmuth; Diane Austin; James B Skatrud; Terry Young
Journal:  Am J Respir Crit Care Med       Date:  2005-09-28       Impact factor: 21.405

Review 4.  Progression from IGT to type 2 diabetes mellitus: the central role of impaired early insulin secretion.

Authors:  Richard E Pratley; Christian Weyer
Journal:  Curr Diab Rep       Date:  2002-06       Impact factor: 4.810

Review 5.  Beta cell function and its relation to insulin action in humans: a critical appraisal.

Authors:  E Ferrannini; A Mari
Journal:  Diabetologia       Date:  2004-04-23       Impact factor: 10.122

6.  Insulin resistance, beta cell dysfunction and visceral adiposity as predictors of incident diabetes: the Insulin Resistance Atherosclerosis Study (IRAS) Family study.

Authors:  A J G Hanley; L E Wagenknecht; J M Norris; M Bryer-Ash; Y I Chen; A M Anderson; R Bergman; S M Haffner
Journal:  Diabetologia       Date:  2009-07-31       Impact factor: 10.122

7.  Individualized pharmacokinetic risk assessment for development of diabetes in high risk population.

Authors:  N Gupta; N H Al-Huniti; P Veng-Pedersen
Journal:  Diabetes Res Clin Pract       Date:  2007-03-19       Impact factor: 5.602

8.  Many Americans have pre-diabetes and should be considered for metformin therapy.

Authors:  Mary K Rhee; Kirsten Herrick; David C Ziemer; Viola Vaccarino; William S Weintraub; K M Venkat Narayan; Paul Kolm; Jennifer G Twombly; Lawrence S Phillips
Journal:  Diabetes Care       Date:  2009-10-06       Impact factor: 19.112

9.  Risk of proteinuria among individuals with persistent borderline diabetes: the Saku study.

Authors:  Yukako Tatsumi; Akiko Morimoto; Fumie Soyano; Tetsuo Shimoda; Naomi Miyamatsu; Yuko Ohno; Shiro Sakaguchi
Journal:  Diabetol Int       Date:  2015-09-04

10.  Development of type 2 diabetes mellitus in people with intermediate hyperglycaemia.

Authors:  Bernd Richter; Bianca Hemmingsen; Maria-Inti Metzendorf; Yemisi Takwoingi
Journal:  Cochrane Database Syst Rev       Date:  2018-10-29
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.